-
Mashup Score: 0
Raj Singh, MD, discusses the use of stereotactic body radiation therapy and stereotactic radiosurgery in the treatment of patients with lung cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2OBX-115 With Acetazolamide Induces Safe and Durable Antitumor Responses in Advanced Melanoma - 4 hour(s) ago
OBX-115 was well tolerated and produced durable antitumor responses in patients with immune checkpoint inhibitor (ICI)-resistant advanced melanoma.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Although FAK inhibition alone has displayed modest activity to date, there is interest in developing FAK-targeted therapies for combination regimens.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 13
Saad Z. Usmani, MD, MBA, FACP, FASCO, discusses the significance of the FDA approval of cilta-cel in relapsed/refractory multiple myeloma.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Overview of Graft-vs-Host Disease (GvHD) - 6 hour(s) ago
Experts on graft-vs-host disease (GvHD) introduce themselves and provide an overview of GvHD, highlighting diagnosis, symptoms, risk stratification, and prevention.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4
Komal L. Jhaveri, MD, FACP, presents key data on the addition of inavolisib to palbociclib and fulvestrant vs palbociclib and fulvestrant alone in select patients with PIK3CA-mutated, hormone receptor–positive, HER2-negative, locally advanced, or metastatic breast cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 15NSCLC Clinical Case Simulations for Practicing Oncologists - 7 hour(s) ago
Welcome to our interactive training module. Please select from below to
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Garje Elucidates Biomarker-Driven Approaches Generating Excitement in Metastatic Prostate Cancer - 9 hour(s) ago
Rohan Garje, MD, highlights advances made in precision medicine approaches for the management of metastatic prostate cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Toxicities Hinder Potential Efficacy of Ceritinib/Trametinib in Pretreated Advanced Melanoma - 10 hour(s) ago
Zeynep Eroglu, MD, discusses how findings from a phase 1/2 study of ceritinib and trametinib could help inform future research in melanoma.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Explore a treatment option for eligible adult patients with newly diagnosed AML that is FLT3-ITD+ - 10 hour(s) ago
Discuss efficacy and safety results from QuANTUM-First, which was a phase 3, randomized, double-blind, placebo-controlled trial exploring VANFLYTA in patients with newly diagnosed FLT3-ITD+ AML Rami Komrokji, MD Senior Member & Professor of Oncologic Sciences Vice Chair-Malignant Hematology Department Moffitt Cancer Center Bhavana (Tina) Bhatnagar, DO Director of Hematology and Medical Oncology Associate Professor of Medicine West Virginia University Cancer Institute – Wheeling Hospital This program is
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
Singh Discusses the Shift Toward Stereotactic Radiation Therapy in Lung Cancer. @OSUCCC_James #oncology #NSCLC https://t.co/yhhArkBSRN